Cannabis and Psychosis – What Are The Links?

We’d like to invite you to a special event, ‘Cannabis and psychosis – what are the links?’, a talk on research findings by Dr Zerrin Atakan, MD, FRCPsych. This is an important opportunity to learn more about a challenging subject from an expert in the field, to ask questions and share experiences. As demand is likely to be high, and places limited, please book your FREE place by emailing londonevents@rethink.org.

Places will be on a first-come, first-served basis. Successful applicants will receive a personal email.

Where: Ambassadors Hotel Bloomsbury, 12 Upper Woburn Place, London WC1H OHX
When: Wednesday, May 7, 2014, from 4pm to 7.30pm

Programme

4pm – Arrival and refreshments

4.30pm – Welcome and introductions

4.40pm – Dr Zerrin Atakan, ‘Cannabis and Psychosis – what are the links?’, followed by Q&A, discussion and sharing of experience

6.10pm – Nigel Campbell, Associate Director of Communications and Marketing, `Rethink Mental Illness – its aims and achievements’

6.30pm – Wine and canapés

About Dr Zerrin Atakan, MD, FRCPsych

After completing her psychiatric training in Hacettepe University, Turkey, Dr Atakan moved to the UK with a research scholarship, where she obtained her membership degree from the Royal College of Psychiatrists. From 1990 until 2003, she worked as a psychiatric intensive care Consultant and from 2003 until 2007 was the Lead Consultant at the National Psychosis Unit at the Maudsley Hospital, London. She now works as an Honorary Senior Lecturer and a Senior Researcher at the Neuroimaging Section of the Institute of Psychiatry, King’s College London, where she studies the effects of cannabis compounds on behaviour and brain regions, as well as developing an intervention model to treat those with psychosis who continue to use substances. She also does private practice. She has written numerous articles on the effects of cannabis in peer-reviewed, high impact journals and makes frequent presentations on cannabis related topics.